Effects of Immunoneutralization of Substance P on Hypothalamic Neurotransmitters in Normal Mice and in Transgenic Mice Expressing Bovine Growth Hormone

Experimental Biology and Medicine

Volumn 218, Issue 1, 1998, Pages 68-75

  Esquifino, Ana I ^a   Arce, Agustin ^a   Debeljuk, Luciano ^b   Bartre, Andrzej ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GROWTH HORMONE; NEUROTRANSMITTER; SUBSTANCE P;

ANIMAL EXPERIMENT; ARTICLE; CASTRATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HORMONE ACTION; HYPOTHALAMUS; MOUSE; NONHUMAN; TRANSGENIC MOUSE;

ANIMALS; CATTLE; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION; GROWTH HORMONE; HYPOTHALAMUS; IMMUNE SERA; LUTEINIZING HORMONE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROTRANSMITTER AGENTS; PITUITARY GLAND, ANTERIOR; PROLACTIN; RABBITS; SUBSTANCE P;

ANIMALIA; BOVINAE; MUS MUSCULUS;

EID: 2542456891     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-218-44269     Document Type: Article

References (25)

1. Tang K, Bartke A, Gardiner CS, Wagner TE, Yun JS. Testosterone feedback on gonadotropin secretion and gene expression in transgenic mice expressing human growth hormone gene. J Androl 15:9-14, 1994.
2. Steger RW, Bartke A, Parkening TA, Collins T, Yun JS, Wagner TE. Neuroendocrine function in transgenic male mice with human growth hormone expression. Neuroendocrinology 52:106-111, 1990.
3. Steger RW, Bartke A, Parkening TA, Collins T, Cerven R, Yun JS, Wagner TE. Effects of chronic exposure to bovine growth hormone (bGH) on the hypothalamic-pituitary axis in transgenic mice: Relationship to the degree of expression of the PEPCK-bGH hybrid gene. Transgenics 1:245-253, 1994.
4. Bartke A, Cecim M, Tang K, Steger RW, Chandrashekar V, Turyn D. Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice. Proc Soc Exp Biol Med 206:345-359, 1994.
5. Doherty PC, Bartke A, Dalterio S, Shuster L, Robertson C. Effects of growth hormone and thryoxine on pituitary and testicular function in two types of hereditary dwarf mice. J Exp Zool 214:53-59, 1980.
6. Bartke A. Histology of the anterior hypophysis, thyroid, and gonads of two types of dwarf mice. Anat Rec 149:225-235, 1964.
7. Steger RW, Bartke A, Parkening TA, Collins T, Buonomo F, Tang K, Wagner TE, Yun JS. Effects of heterologous growth hormones on hypothalamic and pituitary function in transgenic mice. Neuroendocrinology 53:365-372, 1991.
8. Debeljuk L, Ghosh P, Bartke A. Neurokinin A levels in the hypothalamus of rats and mice: Effects of castration, gonadal steroids, and expression of heterologous growth hormone genes. Brain Res Bull 25:717-721, 1990.
9. Ghosh P, Debeljuk L, Wagner TE, Bartke A. Effect of immunoneutralization of neuropeptide Y on gonadotropin and prolactin secretion in normal mice and in transgenic mice bearing bovine growth hormone gene. Endocrinology 129:597-602, 1991.
10. Debeljuk L, Lasaga M, Horvath J, Duvilanski B, Seilicovich A, Diaz MC. Effect of an anti-SP serum on prolactin and gonadotropins in hyperprolactinemic rats. Regul Pept 19:91, 1987.
11. Debeljuk L, Lasaga M, Afione S, Duvilanski B, Diaz MC. Effect of passive immunization against SP in rats with hyperprolactinemia. Peptides 9:933-937, 1988.
12. Jessop DS, Chowdrey HS, Larsen PJ, Lightman SL. Substance P: Multifunctional peptide in the hypothalamo-pituitary system? J Endocrinol 132:331-337, 1992.
13. Mathews LS, Engerg B, Norsted G. Regulation of rat growth hormone gene expression. J Biol Chem 264:9905-9910, 1989.
14. Harvey S, Hull KL, Fraser RA. Growth hormone: Neuroendocrine and neuroendocrine perspectives. Growth Regul 3:161-171, 1993.
15. Kanematsu T, Irahara M, Miyuake T, Shitsukawa K, Toshiriro A, Aono T. Effect of insulin-like growth factor I on gonadotropin release from the hypothalamus-pituitary axis in vitro. Acta Endocrinol 125:227-233, 1991.
16. Mayerhofer A, Weis J, Bartke A, Yun JS, Wagner T. Effects of transgenes for human and bovine growth hormones on age-related changes in ovarian morphology in mice. Anat Rec 117:175-186, 1990.
17. Naar EM, Bartke A, Majumdar SS, Buonomo FC, Yun JS, Wagner TE. Fertility of transgenic female mice expressing bovine growth hormone or human growth hormone variant genes. Biol Reprod 45:178-187, 1991.
18. Debeljuk L, Bartke A. Immunoreactive substance P and neurokinin A in the hypothalamus and anterior pituitary gland of Siberian and Syrian hamsters and of rats. J Reprod Fertil 101:427-434, 1994.
19. Badger TM, Wilcox CE, Meyer ER, Bell RD, Cicero TJ. Simultaneous changes in tissue and serum levels of luteinizing hormone, follicle-stimulating hormone, and LH/FSH-RF after castration in the male rat. Endocrinology 102:136-141, 1978.
20. Steger RW, DePaolo LV, Asch RH, Silverman AY. Interactions of delta 9-tetrahydrocannabinol (THC) with hypothalamic neurotransmitters controlling luteinizing hormone and prolactin release. Neuroendocrinology 37:361-370, 1983.
21. Bartke A, Morgan WW, Clayton RN, Banerji TK, Brodie AM, Parkening TA, Collins TJ. Neuroendocrine studies in hyperprolactinaemic male mice. J Endocrinol 112:215-220, 1987.
22. Afione S, Debeljuk L, Seilicovich A, Pisera D, Lasaga M, Diaz MC, Duvilanski B. Substance P affects the GABAergic system in the hypothalamus-pituitary axis. Peptides 11:1065-1068, 1990.
23. Khan S, Brooks N, Whelpton R, Michael-Titus A. Substance P (1-7) and substance P (5-11) locally modulate dopamine release in rat striaturn. Eur J Pharm 282:229-233, 1995.
24. Reid MS, Herrera-Marschitz M, Terenius L, Ungerstedt V. Intranigral substance P modulation of striatal dopamine: Interaction with N-terminal and C-terminal substance P fragments. Brain Res 526:228-234, 1990.
25. Feuerstein TJ, Gleichauf O, Landwehrmeyer GB. Modulation of cortical acetylcholine by serotonin: The role of substance P interneurons. Naunyn-Schmiedeberg Arch Pharmacol 354:618-626, 1996.